Ultrastructural characteristics (or evaluation) of creutzfeldt-jakob disease and other human transmissible spongiform encephalopathies or prion diseases

Ultrastructural Pathology

Volumn 34, Issue 6, 2010, Pages 351-361

  Liberski, Paweł P ^a   Sikorska, Beata ^a   Hauw, Jean Jacques ^b   Kopp, Nicolas ^c   Streichenberger, Nathalie ^c   Giraud, Pierrie ^c   Boellaard, Jan ^d   Budka, Herbert ^e   Kovacs, Gabor G ^e   Ironside, James ^f   Brown, Paul ^g  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Department of Neurology   (France)

^d Austrian Reference Centre for Human Prion Diseases ^*

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g CEA DSV iMETI SEPIA   (France)

Author keywords

Creutzfeldt Jakob disease; Gerstmann Strussler Scheinker disease; Prion diseases

Indexed keywords

EID: 78349252619     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2010.491175     Document Type: Article

References (65)

1. Liberski PP. Prion diseases: a riddle wrapped in a mistery inside enigma. Folia Neuropathol. 2008;46(2):93-116.
2. Liberski PP, Brown DR, Sikorska B, Caughey B, Brown P. Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropathol. 2008;46:1-25.
3. Brown P, Goldfarb LG, Gajdusek DC. The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet. 1991;337:1019-1022.
4. Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt- Jakob disease: the waning in an era. Neurology. 2006;67:389-393.
5. Almer G, Hainfellner JA, Brucke T, et al. Fatal familial insomnia: a new Austrian family. Brain 1999;122:5-16.
6. Goldfarb LG, Petersen RB, TabatonM, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258:806-808.
7. Parchi P, Castellani R, Cortelli P, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38:21-29.
8. Gambetti P, Parchi P, Chen SG. Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. Clin Lab Med. 2003;23:43-64.
9. Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002;249:1567-1582.
10. Bruce ME, Will RG, Ironside JW, et al. Transmission of mice indicate that new variant CJD is caused by the BSE agent. Nature. 1997;389:498-501.
11. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of new variant CJD. Nature. 1996;383:685-670.
12. Deslys JP, Lasmezas C, Streichenberger N, et al. New variant Creutzfeldt-Jakob disease in France. Lancet. 1997;349:30-31.
13. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature. 1997;389:448-450.
14. Scott MR, Will R, Ironside J, et al. Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA. 1999;96:15137-15142.
15. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921-925.
16. Prusiner SB, Prion Biology and Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2004.
17. Weissmann C. Birth of a prion: spontaneous generation revisited. Cell. 2005;122:165-168.
18. Budka H, Aguzzi A, Brown P, et al. Consensus report: neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;4:459-466.
19. Merz PA, Somerville RA, Wisniewski HM, Iqbal J. Abnormal fibrils from scrapie-infected Brain Acta Neuropathol (Berl). 1981;60:63-74.
20. Merz PA, Rohwer RG, Kascak R, et al. Infection specific particle from the unconventional slow virus diseases. Science. 1984;225:437-476.
21. McKinley MP, Bolton DC, Prusiner SB. A protease resistant protein is a structural component of the scrapie prion. Cell. 1983;35:57-62.
22. Dealler S, Rainov NG. Pentosan polysulfate as a prophylactic and therapeutic agent against prion disease. IDrugs. 2003;6:470-478. Erratum in IDrugs. 2004; 7:88.
23. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987;37:895-904.
24. Liberski PP, Streichenberger N, Giraud P, et al. Ultrastructural pathology of prion diseases revisited: brain biopsy studies. Neuropathol Appl Neurobiol. 2005;31:88-96.
25. Liberski PP, Sikorska B, Hauw JJ, et al. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases. Virus Res. 2008;132:226-228.
26. Liberski PP, Budka H, Sluga E, Barcikowska M, Kwiecinski H. Tubulovesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 1992;84:238-243.
27. Streichenberger N, Jordan D, Verejan I, et al. The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (Berl). 2000;99:704-708.
28. Sikorska B, Liberski PP, Sobow T, Budka H, Ironside JW. Ultrastructural study of florid plaques in variant Creutzfeldt- Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler- Scheinker disease. Neuropathol Appl Neurobiol. 2009;35(1):46-59. [Epub ahead of print 2008 May 30]
29. Hainfellner J, Brantner-Inhaler S, Cervenakova L, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol. 1995;5:201-213.
30. Liberski PP, Budka H. Ultrastructural pathology of Gerstmann- Sträussler-Scheinker disease. Ultrastruct. Pathol. 1995;19:23-36.
31. Boellaard JW, Schlote W. Subakute spongiforme Encephalopathie mit multiformer Plaquebildung: Eigenartige familiar-hereditare Kranknheit des Zentralnervensystems [spino-cerebellare Atrophie mit Demenz, Plaques and plaqueahnlichen im Klein- and Grosshirn (Gerstmann, Sträussler, Scheinker)]. Acta Neuropathol (Berl). 1980;49:205-212.
32. Schlote W, Boellaard JW, Schumm F, Stohr M. Gerstmann- Sträussler-Scheinkers disease: electron microscopic observations on a brain biopsy. Acta Neuropathol (Berl). 1980;52:203-211.
33. Schumm F, Boellaard JW, Schlote W, Stohr M. Morbus Gerstmann- Sträussler-Scheinker. Familie SCh: Ein Bericht uber drei Kranke. Arch Psychiatr Nervenkr. 1981;230:179-196.
34. Brown P, Goldfarb LG, Brown WT, et al. Clinical and molecular genetic study of a large German kindred with Gerstmann- Sträussler-Scheinker syndrome. Neurology. 1991;41:375-379.
35. Liberski PP, Barcikowska M, Cervenakova L, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler- Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol. 1998;96:425-430.
36. Liberski PP, Bratosiewicz J, Barcikowska M, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler- Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol. 2000;100:233-234.
37. Gelpi E, Kovacs GG, Ströbel T, et al. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity. Acta Neuropathol. 2005;110(5):513-519. [Epub 2005 Sep 10]
38. Kopp N, Richard M, Giraud P, et al. Un cas dinsomnie fatale. Rev Neurol (Paris). 2001;157:332-333.
39. Kopp N, Richard M, Liberski PP, et al. A case of fatal familial insomnia: neuropathology and biochemistry. Abstract no C34-05 in Abstracts of the XVth International Congress of Neuropathology, Birmingham, September 3-6, 2000. Brain Pathol. 2000;10:671.
40. Kovacs GG, Preusser M, Strohschneider M, Budka H. Subcellular localization of disease-associated prion protein in the human Brain Am J Pathol. 2005;166:287-294.
41. Liberski PP, Brown P. Disease-specific particles without prion protein in prion diseases-phenomenon or epiphenomenon? Neuropathol Appl Neurobiol. 2007;33:395-397.
42. Jellinger K. Neuroaxonal dystrophy: its natural history and related disorders, In: Zimmerman HM, ed. Progress in Neuropathology, Vol. 2. New York: Grune & Stratton; 1973:129-180.
43. Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Scrapie as a model for neuroaxonal dystrophy: ultrastructural studies. Exp Neurol. 1989;106:133-141.
44. Kovacs GG, Kalev O, Budka H. Contribution of neuropathology to the understanding of human prion disease. Folia Neuropathol. 2004;42(Suppl A):69-76.
45. Liberski PP, Yanagihara R, Gajdusek DC. The spongiform vacuole-the hallmark of slow virus diseases. In: Liberski PP, ed. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. Boca Raton, FL: CRC Press; 1993:155-180.
46. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. The spatial patterns of prion protein deposits in cases of variant Creutzfeldt- Jakob disease. Acta Neuropathol (Berl). 2002;104:665-669.
47. Armstrong RA, Cairns NJ, Lantos PL. Quantification of the vacuolation (spongiform change) and prion protein deposition in 11 patients with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 2001;102:591-596.
48. Zlotnik I. Significance of vacuolated neurones in the medulla of sheep affected with scrapie. Nature. 1957;180:393-394.
49. Beck E, Bak IJ, Christ JF, Gajdusek DC, Gibbs CJ Jr, Hassler R. Experimental kuru in the spider monkey: histopathological and ultrastructural studies of the brain during early stages of incubation. Brain 1975;98:595-612.
50. Beck E, Daniel PM, Davey AJ, Gajdusek DC, Gibbs CJ Jr. The pathogenesis of transmissible spongiform encephalopathy: an ultrastructural study. Brain 1982;105:755-786.
51. Liberski PP, Yanagihara R, Asher DM, Gibbs CJ Jr, Gajdusek DC. Reevaluation of the ultrastructural pathology of experimental Creutzfeldt-Jakob disease. Brain 1990;113: 121-137.
52. Liberski PP, Yanagihara R, Wells GAH, Gibbs CJ Jr, Gajdusek DC. Ultrastructural pathology of axons and myelin in experimental scrapie in hamsters and bovine spongiform encephalopathy in cattle and a comparison with the panencephalopathic type of Creutzfeldt-Jakob disease. J Comp Pathol. 1992;106:383-398.
53. Jeffrey M, Scott JR, Williams A, Fraser H. Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae. Acta Neuropathol (Berl). 1992;84:559-569.
54. Kim JH, Manuelidis EE. Serial ultrastructural study of experimental Creutzfeldt-Jacob disease in guinea pigs. Acta Neuropathol. 1986;69:81-90.
55. Liberski PP, Sikorska B, Bratosiewicz-Wasik J, Gajdusek DC, Brown P. Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. Int J Biochem Cell Biol. 2004;36:2473-2490.
56. David-Ferreira JF, David-Ferreira KL, Gibbs CJ Jr, Morris JA. Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med. 1968;127:313-320.
57. Gibson PH, Doughty LA. An electron microscopic study of inclusion bodies in synaptic terminals of scrapie-infected animals. Acta Neuropathol (Berl). 1989;77:420-425.
58. Liberski PP, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Serial ultrastructural studies of scrapie in hamsters. J Comp Pathol. 1989;101:429-442.
59. Liberski PP, Budka H. Tubulovesicular structures in Gerstmann- Sträussler-Scheinker disease. Acta Neuropathol (Berl). 1994;88:491-492.
60. Narang HK. An electron microscopic study of the scrapie mouse and rat: further observations on virus-like particles with ruthenium red and lanthanum nitrate as a possible trace and negative stain. Neurobiology. 1974;4:349-363.
61. Liberski PP, Jeffrey M, Goodsir C. Tubulovesicular structures are not labeled using antibodies to prion protein (PrP) with the immunogold electron microscopy techniques. Acta Neuropathol (Berl). 1997;93:260-264.
62. Siakotos AN, Raveed D, Longa G. The discovery of a particle unique to brain and spleen subcellular fractions from scrapieinfected mice. J Gen Virol. 1979;43:417-422.
63. Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol (Berl). 1990;79:349-354.
64. Jeffrey M, Goodsir CM, Race RE, Chesebro R. Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann Neurol. 2004;55:781-792.
65. Manuelidis L, Yu ZX, Barquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles. Proc Natl Acad Sci USA. 2007;104: 1965-1970. Erratum in Proc Natl Acad Sci USA. 2007; 104:6090.